38060-08-1,
2-Morpholin-4-yl-1-phenylethylamine,
2-morpholino-1-phenylethanamine,
2-(Morpholin-4-Yl)-1-Phenylethan-1-Amine,
2-morpholin-4-yl-1-phenylethanamine,
2-Morpholin-4-yl-1-phenyl-ethylamine,
F2150-0026,
2-(4-morpholinyl)-1-phenylethanamine,
AC1MDORA,
BAS 09615101,
AC1Q50CZ,
AC1Q50D0,
CHEMBL203233,
SCHEMBL2554004,
2-Morpholin-4-ylphenethyl amine,
4-Morpholineethanamine,a-phenyl-,
CTK4H9261,
DIA-0-0,
DTXSID50384640,
CLAGARRWBBUZDR-UHFFFAOYSA-N,
HMS1704I02,
KS-000029ZJ,
AR3539,
MFCD01862532,
SBB010175,
4-(2-Amino-2-phenylethyl)morpholine,
AKOS000256879,
AKOS016037567,
MCULE-9372371126,
PS-3605,
2-(morpholin-4-yl)-1-phenylethanamine,
SC-92693,
alpha-[(Morpholin-4-yl)methyl]benzylamine,
TR-015410,
FT-0677697,
ST50287657,
EN300-14666,
X-1460,
2-morpholin-4-yl-1-phenylethylamine, AldrichCPR,
I05-2498,
BRD-A82277173-001-01-1,
Z104378298,
CID2814462,
(2-morpholin-4-yl-1-phenylethyl)amine dihydrochloride,